163 related articles for article (PubMed ID: 31952999)
1. A simplified nomogram to assess risk of bladder cancer in patients with a new diagnosis of microscopic hematuria.
Matulewicz RS; Rademaker A; Meeks JJ
Urol Oncol; 2020 Apr; 38(4):240-246. PubMed ID: 31952999
[TBL] [Abstract][Full Text] [Related]
2. Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer.
Cha EK; Tirsar LA; Schwentner C; Hennenlotter J; Christos PJ; Stenzl A; Mian C; Martini T; Pycha A; Shariat SF; Schmitz-Dräger BJ
World J Urol; 2012 Dec; 30(6):847-52. PubMed ID: 23124847
[TBL] [Abstract][Full Text] [Related]
3. Prospective external validation of a bladder cancer detection model.
Lotan Y; Svatek RS; Krabbe LM; Xylinas E; Klatte T; Shariat SF
J Urol; 2014 Nov; 192(5):1343-8. PubMed ID: 24859442
[TBL] [Abstract][Full Text] [Related]
4. Disparities in the diagnostic evaluation of microhematuriaand implications for the detection of urologic malignancy.
Matulewicz RS; Demzik AL; DeLancey JO; Popescu O; Makarov DV; Meeks JJ
Urol Oncol; 2019 May; 37(5):300.e1-300.e7. PubMed ID: 30661870
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Diagnostic Yield of Cystoscopy and Computed Tomographic Urography for Urinary Tract Cancers in Patients Evaluated for Microhematuria: A Systematic Review and Meta-analysis.
Waisbrod S; Natsos A; Wettstein MS; Saba K; Hermanns T; Fankhauser CD; Müller A
JAMA Netw Open; 2021 May; 4(5):e218409. PubMed ID: 33970257
[TBL] [Abstract][Full Text] [Related]
6. The Prevalence of Bladder Cancer During Cystoscopy for Asymptomatic Microscopic Hematuria.
Gonzalez AN; Lipsky MJ; Li G; Rutman MP; Cooper KL; Weiner DM; Badalato G; Decastro GJ; Wenske S; McKiernan JM; Anderson CB
Urology; 2019 Apr; 126():34-38. PubMed ID: 30677457
[TBL] [Abstract][Full Text] [Related]
7. Novel nomograms to predict recurrence and progression in primary non-muscle-invasive bladder cancer: validation of predictive efficacy in comparison with European Organization of Research and Treatment of Cancer scoring system.
Kim HS; Jeong CW; Kwak C; Kim HH; Ku JH
World J Urol; 2019 Sep; 37(9):1867-1877. PubMed ID: 30535715
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of patients with a negative work-up for asymptomatic microhematuria.
Madeb R; Golijanin D; Knopf J; Davis M; Feng C; Fender A; Stephenson L; Messing EM
Urology; 2010 Jan; 75(1):20-5. PubMed ID: 19913883
[TBL] [Abstract][Full Text] [Related]
9. A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma.
Kavalieris L; O'Sullivan PJ; Suttie JM; Pownall BK; Gilling PJ; Chemasle C; Darling DG
BMC Urol; 2015 Mar; 15():23. PubMed ID: 25888331
[TBL] [Abstract][Full Text] [Related]
10. A Nomogram Derived by Combination of Demographic and Biomarker Data Improves the Noninvasive Evaluation of Patients at Risk for Bladder Cancer.
Huang S; Kou L; Furuya H; Yu C; Goodison S; Kattan MW; Garmire L; Rosser CJ
Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1361-6. PubMed ID: 27383773
[TBL] [Abstract][Full Text] [Related]
11. Hematuria Cancer Risk Score with Ultrasound Informs Cystoscopy Use in Patients with Hematuria.
Tan WS; Ahmad A; Zhou Y; Nathan A; Ogunbo A; Gbolahan O; Kallam N; Smith R; Khalifeh M; Tan WP; Cohen D; Volanis D; Walter FM; Sasieni P; Kamat AM; Kelly JD
Eur Urol Oncol; 2024 May; ():. PubMed ID: 38811250
[TBL] [Abstract][Full Text] [Related]
12. Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria.
Loo RK; Lieberman SF; Slezak JM; Landa HM; Mariani AJ; Nicolaisen G; Aspera AM; Jacobsen SJ
Mayo Clin Proc; 2013 Feb; 88(2):129-38. PubMed ID: 23312369
[TBL] [Abstract][Full Text] [Related]
13. A predictive nomogram for individualized recurrence stratification of bladder cancer using multiparametric MRI and clinical risk factors.
Xu X; Wang H; Du P; Zhang F; Li S; Zhang Z; Yuan J; Liang Z; Zhang X; Guo Y; Liu Y; Lu H
J Magn Reson Imaging; 2019 Dec; 50(6):1893-1904. PubMed ID: 30980695
[TBL] [Abstract][Full Text] [Related]
14. Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection.
Lotan Y; Capitanio U; Shariat SF; Hutterer GC; Karakiewicz PI
BJU Int; 2009 May; 103(10):1368-74. PubMed ID: 19338566
[TBL] [Abstract][Full Text] [Related]
15. Sex and the Diagnostic Pathway to Bladder Cancer among Veterans: No Evidence of Disparity.
Lynch KE; Viernes B; Khader K; DuVall SL; Schroeck FR
Womens Health Issues; 2020; 30(2):128-135. PubMed ID: 31870696
[TBL] [Abstract][Full Text] [Related]
16. Nomograms including the UBC
Meisl CJ; Karakiewicz PI; Einarsson R; Koch S; Hallmann S; Weiß S; Hemdan T; Malmström PU; Styrke J; Sherif A; Hasan MN; Pichler R; Tulchiner G; Palou J; Rodríguez Faba Ó; Hennenlotter J; Stenzl A; Ritter R; Niegisch G; Grunewald CM; Schlomm T; Friedersdorff F; Barski D; Otto T; Gössl A; Arndt C; Esuvaranathan K; Kesavan NR; Zhijiang Z; Kramer MW; Hennig MJP; Ecke TH
BJU Int; 2022 Dec; 130(6):754-763. PubMed ID: 34928524
[TBL] [Abstract][Full Text] [Related]
17. Development and external validation of a nomogram to predict high-grade papillary bladder cancer before first-time transurethral resection of the bladder tumor.
Wakai K; Utsumi T; Yoneda K; Oka R; Endo T; Yano M; Fujimura M; Kamiya N; Sekita N; Mikami K; Sugano I; Hiruta N; Suzuki H
Int J Clin Oncol; 2018 Oct; 23(5):957-964. PubMed ID: 29804156
[TBL] [Abstract][Full Text] [Related]
18. Dipstick Urinalysis as a Test for Microhematuria and Occult Bladder Cancer.
Matulewicz RS; DeLancey JO; Pavey E; Schaeffer EM; Popescu O; Meeks JJ
Bladder Cancer; 2017 Jan; 3(1):45-49. PubMed ID: 28149934
[No Abstract] [Full Text] [Related]
19. Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis.
Garg T; Pinheiro LC; Atoria CL; Donat SM; Weissman JS; Herr HW; Elkin EB
J Urol; 2014 Oct; 192(4):1072-7. PubMed ID: 24835058
[TBL] [Abstract][Full Text] [Related]
20. External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder.
Al-Daghmin A; English S; Kauffman EC; Din R; Khan A; Syed JR; Sztorc J; Mehedint D; Sharif M; Shi Y; Wilding G; Guru KA
BJU Int; 2014 Aug; 114(2):253-60. PubMed ID: 24119175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
